1. Significance of nuclear factor - kappa beta activation on prostate needle biopsy samples in the evaluation of Gleason score 6 prostatic carcinoma indolenceMarko Zupančič, Boris Pospihalj, Snežana Cerović, Barbara Gazić, Primož Drev, Marko Hočevar, Andraž Perhavec, 2020, izvirni znanstveni članek Povzetek: The goal of our study was to find out whether the immunohistochemical expression of nuclear factor-kappa beta (NF-%B) p65 in biopsy samples with Gleason score 3 + 3 = 6 (GS 6) can be a negative predictive factor for Prostate cancer (PCa) indolence. Patients and methods Study was conducted on a retrospective cohort of 123 PCa patients with initial total PSA % 10 ng/ml, number of needle biopsy specimens % 8, GS 6 on biopsy and T1/T2 estimated clinical stage who underwent laparoscopic radical prostatectomy and whose archived formalin-fixed and paraffin-embedded (FFPE) prostate needle biopsy specimens were used for additional immunohistochemistry staining for detection of NF-%B p65. Both cytoplasmic and nuclear NF-%B p65 expression in biopsy cores with PCa were correlated with postoperative pathological stage, positive surgical margins, GS and biochemical progression of disease. Results After follow-up of 66 months, biochemical progression (PSA % 0.2 ng/ml) occurred in 6 (5.1%) patients, 3 (50%) with GS 6 and 3 (50%) with GS 7 after radical prostatectomy. Both cytoplasmic and nuclear NF-%B p65 expressions were not significantly associated with pathological stage, positive surgical margin and postoperative GS. Patients with positive cytoplasmic NF-kB reaction had significantly more frequent biochemical progression than those with negative cytoplasmic NF-kB reaction with PSA 0.2 ng/ml as cutoff point (p = 0.015) and a trend towards more biochemical progression with PSA % 0.05 ng/ml as cutoff point (p = 0.068). Conclusions Cytoplasmic expression of NF-%B is associated with more biochemical progression and might be an independent prognostic factor for recurrence-free survival (RFS), but further studies including larger patient cohorts are needed to confirm these initial results.
Ključne besede: prostate cancer, needle biopsy, nuclear factor-kappa beta, Gleason
Objavljeno v DiRROS: 12.07.2024; Ogledov: 47; Prenosov: 22
 Celotno besedilo (399,54 KB)
Gradivo ima več datotek! Več... |
2. Izraženost ER in PR pri invazivnem karcinomu dojke : rezultati določanja na 15 029 zaporednih vzorcih z Onkološkega Inštituta v obdobju 2006 do 2021Primož Drev, Olga Blatnik, Jerca Blazina, Juan Antonio Contreras, Gorana Gašljević, Biljana Grčar-Kuzmanov, Andreja Klevišar Ivančič, Snežana Pavlović Djokić, Barbara Gazić, 2022, objavljeni povzetek strokovnega prispevka na konferenci Ključne besede: onkologija, rak dojke, patologija
Objavljeno v DiRROS: 14.02.2023; Ogledov: 544; Prenosov: 171
Celotno besedilo (79,90 KB) |
3. Izraženost hormonskih receptorjev pri invazivnem karcinomu dojke : rezultati določanja na 15029 zaporednih vzorcih z Onkološkega Inštituta v obdobju od 2006 do 2021Barbara Gazić, Olga Blatnik, Jerca Blazina, Juan Antonio Contreras, Gorana Gašljević, Biljana Grčar-Kuzmanov, Andreja Klevišar Ivančič, Snežana Pavlović Djokić, Primož Drev, 2022, objavljeni povzetek strokovnega prispevka na konferenci Ključne besede: onkologija, rak dojke, patologija
Objavljeno v DiRROS: 14.02.2023; Ogledov: 567; Prenosov: 128
Celotno besedilo (87,23 KB) |
4. HER2 pri invazivnem karcinomu dojke – rezultati določanja na 15 184 zaporednih vzorcih z Onkološkega Inštituta v obdobju 2006 do 2021Primož Drev, Olga Blatnik, Jerca Blazina, Juan Antonio Contreras, Gorana Gašljević, Biljana Grčar-Kuzmanov, Andreja Klevišar Ivančič, Snežana Pavlović Djokić, Barbara Gazić, 2022, objavljeni povzetek strokovnega prispevka na konferenci Ključne besede: onkologija, rak dojke, patologija
Objavljeno v DiRROS: 14.02.2023; Ogledov: 504; Prenosov: 125
Celotno besedilo (107,23 KB) |
5. Prediktivna vloga tumorske limfocitne infiltracije za dosego popolnega patološkega odgovora po predoperativnem sistemskem zdravljenju pri zgodnjem raku dojkeKlara Geršak, Barbara Gazić, Andreja Klevišar Ivančič, Primož Drev, Nina Ružić Gorenjec, Cvetka Grašič-Kuhar, 2022, objavljeni povzetek strokovnega prispevka na konferenci Ključne besede: onkologija, rak dojke, kemoterapija
Objavljeno v DiRROS: 03.02.2023; Ogledov: 523; Prenosov: 127
Celotno besedilo (38,68 KB) |
6. Vpliv opustitve dopolnilne kemoterapije na preživetje bolnic z zgodnjim ER+/HER2+ rakom dojkValentina Jerič Horvat, Damjan Manevski, Barbara Gazić, Primož Drev, Domen Ribnikar, Erika Matos, Boštjan Šeruga, 2022, objavljeni povzetek strokovnega prispevka na konferenci Ključne besede: onkologija, rak dojke, kemoterapija
Objavljeno v DiRROS: 27.01.2023; Ogledov: 506; Prenosov: 146
Celotno besedilo (47,33 KB) |
7. |
